Global surgery, obstetric, and anaesthesia indicator definitions and reporting: An Utstein consensus report.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
03
09
2021
pubmed:
21
8
2021
medline:
11
11
2021
entrez:
20
8
2021
Statut:
epublish
Résumé
Indicators to evaluate progress towards timely access to safe surgical, anaesthesia, and obstetric (SAO) care were proposed in 2015 by the Lancet Commission on Global Surgery. These aimed to capture access to surgery, surgical workforce, surgical volume, perioperative mortality rate, and catastrophic and impoverishing financial consequences of surgery. Despite being rapidly taken up by practitioners, data points from which to derive the indicators were not defined, limiting comparability across time or settings. We convened global experts to evaluate and explicitly define-for the first time-the indicators to improve comparability and support achievement of 2030 goals to improve access to safe affordable surgical and anaesthesia care globally. The Utstein process for developing and reporting guidelines through a consensus building process was followed. In-person discussions at a 2-day meeting were followed by an iterative process conducted by email and virtual group meetings until consensus was reached. The meeting was held between June 16 to 18, 2019; discussions continued until August 2020. Participants consisted of experts in surgery, anaesthesia, and obstetric care, data science, and health indicators from high-, middle-, and low-income countries. Considering each of the 6 indicators in turn, we refined overarching descriptions and agreed upon data points needed for construction of each indicator at current time (basic data points), and as each evolves over 2 to 5 (intermediate) and >5 year (full) time frames. We removed one of the original 6 indicators (one of 2 financial risk protection indicators was eliminated) and refined descriptions and defined data points required to construct the 5 remaining indicators: geospatial access, workforce, surgical volume, perioperative mortality, and catastrophic expenditure. A strength of the process was the number of people from global institutes and multilateral agencies involved in the collection and reporting of global health metrics; a limitation was the limited number of participants from low- or middle-income countries-who only made up 21% of the total attendees. To track global progress towards timely access to quality SAO care, these indicators-at the basic level-should be implemented universally as soon as possible. Intermediate and full indicator sets should be achieved by all countries over time. Meanwhile, these evolutions can assist in the short term in developing national surgical plans and collecting more detailed data for research studies.
Sections du résumé
BACKGROUND
Indicators to evaluate progress towards timely access to safe surgical, anaesthesia, and obstetric (SAO) care were proposed in 2015 by the Lancet Commission on Global Surgery. These aimed to capture access to surgery, surgical workforce, surgical volume, perioperative mortality rate, and catastrophic and impoverishing financial consequences of surgery. Despite being rapidly taken up by practitioners, data points from which to derive the indicators were not defined, limiting comparability across time or settings. We convened global experts to evaluate and explicitly define-for the first time-the indicators to improve comparability and support achievement of 2030 goals to improve access to safe affordable surgical and anaesthesia care globally.
METHODS AND FINDINGS
The Utstein process for developing and reporting guidelines through a consensus building process was followed. In-person discussions at a 2-day meeting were followed by an iterative process conducted by email and virtual group meetings until consensus was reached. The meeting was held between June 16 to 18, 2019; discussions continued until August 2020. Participants consisted of experts in surgery, anaesthesia, and obstetric care, data science, and health indicators from high-, middle-, and low-income countries. Considering each of the 6 indicators in turn, we refined overarching descriptions and agreed upon data points needed for construction of each indicator at current time (basic data points), and as each evolves over 2 to 5 (intermediate) and >5 year (full) time frames. We removed one of the original 6 indicators (one of 2 financial risk protection indicators was eliminated) and refined descriptions and defined data points required to construct the 5 remaining indicators: geospatial access, workforce, surgical volume, perioperative mortality, and catastrophic expenditure. A strength of the process was the number of people from global institutes and multilateral agencies involved in the collection and reporting of global health metrics; a limitation was the limited number of participants from low- or middle-income countries-who only made up 21% of the total attendees.
CONCLUSIONS
To track global progress towards timely access to quality SAO care, these indicators-at the basic level-should be implemented universally as soon as possible. Intermediate and full indicator sets should be achieved by all countries over time. Meanwhile, these evolutions can assist in the short term in developing national surgical plans and collecting more detailed data for research studies.
Identifiants
pubmed: 34415914
doi: 10.1371/journal.pmed.1003749
pii: PMEDICINE-D-20-05959
pmc: PMC8415575
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003749Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Tore Laerdal is Executive Director of the Laerdal Foundation, which provided financial support for the meeting. Tore provided practical support for the meeting and read and approved the manuscript, but did not input into the consensus process or conclusions.
Références
Soc Sci Med. 2016 Oct;166:86-93
pubmed: 27543685
Int J Gynaecol Obstet. 2019 Jul;146(1):3-7
pubmed: 30927443
Lancet. 2018 Apr 21;391(10130):1589-1598
pubmed: 29306587
BMJ Glob Health. 2017 May 18;2(2):e000226
pubmed: 28589025
Circulation. 2007 Nov 20;116(21):2481-500
pubmed: 17993478
Circulation. 2003 Nov 18;108(20):2565-74
pubmed: 14623794
Can J Anaesth. 2019 Feb;66(2):218-229
pubmed: 30484168
Lancet Glob Health. 2014 Jun;2(6):e334-45
pubmed: 25103302
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Lancet. 2015 Aug 8;386(9993):569-624
pubmed: 25924834
Lancet. 2020 May 2;395(10234):1452-1456
pubmed: 32305072
Lancet. 2009 Sep 26;374(9695):1113-7
pubmed: 19782877
Anesth Analg. 2018 Apr;126(4):1329-1339
pubmed: 29547428
BMJ Glob Health. 2018 Dec 1;3(6):e001005
pubmed: 30588342
Ann Surg. 2020 Nov 17;:
pubmed: 33214454
Lancet Glob Health. 2015 Aug;3(8):e487-e495
pubmed: 26187491
Br J Surg. 2019 Jan;106(2):e138-e150
pubmed: 30570764
BMJ Glob Health. 2017 Nov 25;2(4):e000376
pubmed: 29225948
Circulation. 2004 Nov 23;110(21):3385-97
pubmed: 15557386
Lancet. 2015 Aug 8;386(9993):507-9
pubmed: 25924835
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):
pubmed: 28716971
World J Surg. 2020 Dec;44(12):3986-3992
pubmed: 32920705
Lancet. 2015 May 30;385(9983):2209-19
pubmed: 25662414
Bull World Health Organ. 2016 Mar 1;94(3):201-209F
pubmed: 26966331
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
Lancet Glob Health. 2020 May;8(5):e699-e710
pubmed: 32353317
Ann Surg. 2017 Aug;266(2):389-399
pubmed: 27611619
Lancet. 2015 Apr 27;385 Suppl 2:S27
pubmed: 26313074
Surgery. 2015 Jul;158(1):17-26
pubmed: 25958067